Notícias e Atividades da Tevogen Bio
Presença
Tevogen Bio é uma empresa listada sob o símbolo TVGN (US).
Executivos
Veja o organograma con seus 16 executivos principais
Biografias mais buscadas da Tevogen Bio
- Ryan Saadi, Chairman of the Board and Chief Executive Officer
- Curtis Patton, Director
- Lindee Goh, Director
Recentes movimentos de executivos em Tevogen Bio
- David Banko, ingressou na Companhia como Global Head, Government Affairs and Patient Access (Notícia publicada em 26 de março de 2025).
Criar um alerta
para seguir os movimentos de executivos da Tevogen Bio.
Biotecnologia
Tevogen Bio possui 2.339 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Biogen (Estados Unidos).
Popular M&A news in Biotecnologia
- Jade Biosciences and Aerovate Therapeutics have announced they will merge (publicado em 30 de abril de 2025)..
- Deepull acaba de anunciar uma arrecadação de fundos de 50 milhões de dólares. (publicado em 29 de abril de 2025).
- Biolinq acaba de anunciar uma arrecadação de fundos de 100 milhões de dólares. (publicado em 23 de abril de 2025).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Tevogen Bio
- Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts
- Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
- Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion
- Tevogen Bio Announces 2025 Annual Meeting
- Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility
- Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a Precision AI Tool for Target Prediction
- Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
- Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission
- Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump’s Initiative to Encourage Pharmaceutical Manufacturing in United States
- Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
- View more press releases Close
Redes sociais sobre Tevogen Bio
- Tevogen Bio na Wikipedia, Google News e Yahoo Finance
- Tevogen Bio na LinkedIn, Twitter e YouTube
